NVO News and Press, Novo Nordisk A/S From 05/10/24

2024-05-10 02:08:25 ET Summary iShares MSCI Denmark ETF has $290M in assets and tracks the MSCI Denmark index. EDEN is heavily concentrated in the Health Care sector, with 42% of its assets allocated there. The fund has significant allocations in industrials and financials, an...

2024-05-09 13:22:28 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Catalent, Novo Nordisk receive FTC request for mo...

2024-05-09 09:45:00 ET Novo Nordisk (NYSE: NVO) has been a great investment over the past few years. Since the start of 2022, shares of the Danish healthcare giant have risen by 120%, far outstripping the S&P 500 's return of just 8%. The company is a big name in diabetes ca...

2024-05-07 14:04:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because much hinges on underlying breakthroughs. Never...

2024-05-07 13:24:47 ET More on Fresenius Medical Care Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript Fresenius Medical Care AG 2023 Q4 - Results - Earnings Call P...

2024-05-04 15:30:00 ET Read the full article on Seeking Alpha For further details see: Pharma R&D productivity seen improving for the first time in years - Deloitte

2024-05-04 09:13:02 ET Summary Amgen's shares surged after management's earnings call comments about the phase 2 trial of obesity candidate MariTide. These comments and previous phase 2 data point to the increasing possibility of Amgen becoming a real contender in the rapidly expa...

2024-05-03 13:45:54 ET Summary The FTC is investigating improper patent listings, including Novo Nordisk's Ozempic, which could impact shareholders. Novo Nordisk's GLP-1 agonists, including Ozempic, have become a significant part of the company's revenue. The scrutiny from the...

2024-05-03 10:28:54 ET More on Amgen Amgen, Inc. (AMGN) Q1 2024 Earnings Call Transcript Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Biggest stock movers today: WOW, AAPL, SQ, and more Amge...

2024-05-03 09:26:24 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent gains after filing 10-Q FTC likely to look at Catalent alternatives in review of Novo deal - report Seeking Alpha’s Quant Rating on Catalent His...